Atrium Therapeutics awards new hire options for 13,500 shares, RSUs for 6,750 shares under inducement plan

Bitget2026/09/21 20:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Atrium Therapeutics awarded inducement equity grants on Sept. 20, 2026 to one newly hired non-executive under its 2026 Employment Inducement Incentive Award Plan.
Grant included non-qualified stock options for 13,500 shares with an exercise price of USD 8.95.
Options vest 25% after one year, then monthly over 36 months, subject to continued service.
Grant also included 6,750 restricted stock units, vesting 25% after one year, then annually over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atrium Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA53090) on September 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Atrium Therapeutics awards new hire options for 13,500 shares, RSUs for 6,750 shares under inducement plan

You may also like

Crypto prices